Oligoribonucleotides containing 4-thiouridine were prepared using the Fpmp group for protection of the 2'-OH. Two uridine derivatives with the 1,2,4-triazolyl and the 2-nitrophenyl groups at position 4 were used to obtain 4-thiouridine by postsynthetic substitution with sodium hydrogen sulfide. Both uridine derivatives allow the preparation of the desired oligonucleotides in good yields.
INTRODUCTION
Photochemical cross-linking can be used to characterize RNA-protein interactions by trapping transient complexes, which can be difficult to isolate. [1] [2] [3] One of the most common strategies used in photochemical photochemical cross-linking is to incorporate photoreactive nucleotide analogs at defined positions. These photoreactive nucleotides can be incorporated into the RNA chains by in vitro transcription and/or RNA ligation. [1] [2] [3] Recent advances in chemical synthesis of RNA have opened up the possibility of obtaining short RNA molecules containing some of these photoreactive nucleosides by chemical synthesis.
Specifically the synthesis of oligoribonucleotides containing the photoreactive nucleosides 5-bromo-, 5-iodo-and 4-thiouridine has been described. [4] [5] [6] [7] [8] For the preparation of 5-thiouridine oligoribonucleotides, the S-cyanoethyl-protected 4-thiouridine phosphoramidite derivative 4, 6, 7 has been used.
Another possibility is to prepare an uridine derivative carrying a leaving group in position 4.
After the assembly of the desired sequence this derivative can be converted to thiouridine by nucleophilic displacement with a thiol. This strategy, known as the convertible nucleoside approach 9 or the postsynthetic modification approach 10 , has been used to prepare oligoribonucleotides carrying N-alkyl-cytosine derivatives 11 and 4-thiouridine 5, 8 . In these studies, 2'-OH were protected as a tert-butyldimethylsilyl (TBDMS) ethers.
We are interested in the preparation of oligoribonucleotides carrying photoreactive nucleosides such as 4-thiouridine. In this paper, we describe the preparation and use of two uridine derivatives for the synthesis of 4-thiouridine oligoribonucleotides. The 2'-OH of the phosphoramidite derivatives is protected by the 1-(2-fluorophenyl)-4-methoxypiperidin-4-yl (Fpmp) group [12] [13] [14] . In this way, Fpmp-protected RNA intermediates can be isolated, facilitating the characterization of the products.
RESULTS AND DISCUSSION
Preparation of Oligonucleotides Carrying 4-Thiouridine Using the 1,2,4-Triazolyl Derivative of Uridine.
Nucleoside derivatives carrying good leaving groups at specific positions can be used to obtain oligonucleotides carrying modified bases 4, 5, [8] [9] [10] [11] . The 1,2,4-triazolyl group 5,15,16 was first selected to activate the position 4 of the uracil base in order to obtain 4-thiouridine. To study the displacement conditions we prepared the 1,2,4-triazolyl derivative of 2',3',5'-tri- Figure 1 ) was reacted with a solution of phosphoryl tristriazolide 5,16 prepared by mixing POCl 3 , 1,2,4-triazol and triethylamine in dry CH 3 CN. Compound 2 was then treated with a 0.2 M solution of thiolacetic acid in CH 3 CN and with a 0.2 M solution of NaSH in dimethylformamide (DMF). Both gave the desired 2',3',5'-tri-O-acetyl-4-thiouridine (3, Figure 1 ) but the reaction with NaSH was faster finishing after 3 hr at room temperature.
FIGURE 1
Next, the commercially available uridine phosphoramidite carrying the Fpmp group for the protection of the 2'-OH was reacted with the phosphoryl tristriazolide 5 solution giving compound 4 (Figure 1 ) in 85% yield after purification on silica gel.
Phosphoramidite 4 was reacted with thymidine linked to a controlled pore glass (CPG) support to obtain after regular phosphite oxidation the dinucleotide sequence A: 5' tri UT 3'
(where tri U is 4-(1,2,4-triazol-1-yl)-2-pyrimidon-1-yl-β-D-ribofuranoside). The coupling reaction of phosphoramidite 4 proceeded in 95% yield, according to the absorbance of the DMT group released after the coupling reaction. The resulting support was then treated with a 0.2 M NaSH solution in DMF at room temperature for 3 hours, and, afterwards, with conc.
NH 3 for 1 hr at room temperature to release the dinucleotide from the support and remove the cyanoethyl group. Only one peak was observed, which was collected and found to have the expected molecular weight.
Oligoribonucleotide sequences B: 5' tri UG 3' and C: 5'CUAGU( tri U)CGAU 3' were assembled on a DNA synthesizer using Fpmp-protected nucleoside 2-cyanoethyl phosphoramidites and solid supports. The resulting supports were treated with a 0.2 M NaSH solution in DMF, and with conc. NH 3 . In these oligonucleotides ammonia treatment must be longer than one hour in order to remove the protecting groups of the bases. The effect of the ammonia treatment was studied on the dinucleotide B. Overnight treatment at 50ºC removed the thiol group of 4-thiouridine yielding the dinucleotide carrying cytidine or uridine. The side product is more polar than the desired oligonucleotide and it is easily separated by HPLC (see Figure 2b ). In this way, the side product was isolated and characterized by mass spectrometry (MS, electrospray, found1002.4 expected for C Fpmp G Fpmp 1002.8, expected for U Fpmp G Fpmp 1003.8). The formation of this side product is reduced by lowering the temperature (24 hr, at room temperature) or the time of the ammonia treatment (4 h, 50ºC, Figure 2a ). Using a 4 h treatment at 50ºC decamer C was obtained as the major product, and had the expected molecular weight. Dinucleotide 5' 4S UG 3' was used to initiate the transcription by T7 RNA polymerase. In this way, longer RNA transcripts with 4-thiouridine at the 5'-end were obtained and used to study proteins involved in RNA splicing, as described previously 18 .
FIGURE 2
We also found that samples with the (1,2,4-triazolyl) derivative should be processed rapidly.
After three months, both the phosphoramidite 4 and oligonucleotide supports carrying the 
FIGURE 3
Phosphoramidite 9 was reacted with thymidine linked to a controlled pore glass (CPG) support to obtain the dinucleotide sequence A: 5' np UT 3' (being np U: 4-(2-nitrophenyl)-uridine. The coupling reaction of phosphoramidite 9 proceeded in 94% yield, similar to the Fpmp phosphoramidites of the natural nucleosides. The resulting support was then treated with a 0.2 M NaSH solution, and with conc. NH 3 at room temperature. Only one peak was observed, which was collected and found to have the expected molecular weight.
Oligoribonucleotide sequence E: 5' UAC( np U)GU 3' was prepared using the appropriate Fpmp phosphoramidites. The support was treated with a 0.2 M NaSH solution and the resulting support was then treated with conc. ammonia as described above, producing the desired thiouridine oligonucleotide in good yields. This phosphoramidite maintained its properties for at least two years when frozen.
FIGURE 4 CONCLUSION
We have shown that oligoribonucleotides containing 4-thiouridine can be prepared from two different precursors: first, the 4-(1,2,4-triazolyl) derivative which can be obtained from the readily available uridine phosphoramidite carrying the Fpmp group at position 2' but which has a limited shelf-life; second, the 4-(2-nitrophenyl) derivative, which requires a longer synthetic scheme but, once prepared, presents a longer shelf-life. These derivatives may be also used for N-15 labelling and preparation of oligonucleotides carrying N-alkyl-C derivatives similarly as described with the 4-chlorophenyl uridine derivative. General Procedures. Solvents, including those of HPLC grade, were from SDS and E.
Merck. Reagents were from Aldrich and Fluka and were used without further purification.
Analytical TLC was run on aluminium sheets coated with silica gel 60 F 254 from Merck. Standard Work-Up. All reactions were carried out in oven-dried glassware, under a nitrogen or argon atmosphere, unless specified otherwise. Before use, starting materials were dried by evaporation with the dry solvent that will be used for the reaction. Once the reaction was completed, solutions were concentrated to dryness and the residues were dissolved in CH 2 Cl 2 or CHCl 3 and washed with 5% aqueous NaHCO 3 and saturated aqueous NaCl. The organic phase was dried (Na 2 SO 4 ) and the solvent was removed.
To an ice-cooled stirred suspension of 1,2,4-triazole (1,5 g, 21.7 mmol) in dry CH 3 CN (30 ml) 0.42 ml (4.2 mmol) of POCl 3 were added, followed by 3.27 ml ( 23.4 mmol) of dry Et 3 N. After 30 min a solution of 2´,3',5'-tri-O-acetyluridine 17 (1) (2 mmol) in dry CH 3 CN was added over a period of 15 min and stirred for 2 h. The reaction was stopped by addition of 25 ml of a saturated NaHCO 3 aqueous solution and, 50 ml of ethyl acetate were added.
The organic phase was washed with brine, dried over Na 2 SO 4 and concentrated to dryness.
The resulting product (0.85 g unpurified with Et 3 N) was used in the next step without further purification. TLC (10% MeOH in CH 2 Cl 2 ) one single fluorescent spot of Rf = 0.7. UV (max, MeOH) 243, 302 nm.
2',3',5'-Tri-O-acetyl-4-thiouridine (3).
1) Reaction with thiolacetic acid. Compound 2 (0.24 mmol) was treated with 0.142 ml (2 mmol) of thiolacetic acid dissolved in 10 ml of CH 3 CN. After one day of magnetic stirring at room temperature conversion to 2',3',5'-triacetyl thiouridine was judged to be around 50% by TLC (10% CH 3 OH in CH 2 Cl 2 , starting material Rf= 0.7 fluorescent, final product Rf= 0.8 non fluorescent). After 2 days the reaction was practically finished. The reaction mixture was concentrated to dryness and treated using the standard work-up described above. The product was purified by column chromatography. Yield: 58% (53 mg, 0.14 mmol). Physical and spectroscopic data agreed with literature values 20 .
2) Reaction with sodium hydrogen sulfide. 2',3',5'-O-Triacetyl-4-(1,2,4-triazolyl)uridine (0.24 mmol) was treated with 148.2 mg (2 mmol) of sodium hydrogensulfide in 10 ml DMF.
After 3 hr of magnetic stirring the conversion was judged to be completed by TLC (see above). The reaction mixture was concentrated to dryness and treated using the standard work-up described above. The product was purified by column chromatography. Yield: 62 % (60 mg, 0.15 mmol. Physical and spectroscopic data agreed with literature values 20 .
5'-O-Dimethoxytrityl-2'-O-[1-(2-fluorophenyl)-4-methoxypiperidin-4-yl]-4-(1,2,4-triazolyl)uridine 3'-O-[2-cyanoethyl-N,N-(diisopropylamino)] phosphoramidite (4).
The protocol described by Shah et al. 5 was used for the preparation of this phosphoramidite.
To an ice-cooled suspension of 1,2,4-Triazole (1.04 g, 15.5 mmol) in dry CH 3 CN (20 ml) was added 0.3 ml of POCl 3 was added, followed by 2.25 ml of dry Et 3 N. After 30 min a solution of the DMT-U(Fpmp) phosphoramidite (188 mg, 0.25 mmol) in dry CH 3 CN was added over a period of 15 min and stirring was continued for 2 hr. After standard work-up, the product was purified by column chromatography (ethyl acetate/ CH 2 Cl 2 2:3 + 1% triethylamine). Yield 170 mg, 85%. The reaction mixture was stirred overnight under anhydrous conditions, whereupon TLC showed an almost complete reaction. Triethylamine was added and after 5 minutes, THF was evaporated and the residue was dissolved in CH 2 Cl 2 . The solution was treated with the standard work-up described above. The residue was purified on silica gel using a 0-4% .
Compound 7 (1.24g , 2.16 mmol) was dried by evaporation of pyridine (3 x 1,5 ml) in vacuo. Anhydrous pyridine (30 ml) and 4,4'-dimethoxytrityl chloride (0.9 g 2.65 mmol)
were added with stirring and exclusion of moisture. Silica gel TLC in triethylamine / ethanol / CH 2 Cl 2 (1:10:89, v/v/v) showed a complete reaction after 1.5 h with a new spot of Rf. 0.65.
The reaction was quenched by addition of methanol (5 ml) and the solvent was removed in vacuo. The residual oil was dissolved in ethyl acetate (50 ml) and the solution was washed as described above in the standard work-up. Residual pyridine was removed by evaporation of toluene in vacuo. The crude product was purified by column chromatography. The column was packed using a 1% triethylamine solution in CH 2 Cl 2 and the product was eluted with a 0-10% methanol gradient in CH 2 Cl 2 . .
Compound 8 (1g , 1.14 mmol) was dried by evaporation of dry CH 3 CN (3 x 10 ml) in vacuo.
The residual foam was dissolved in dry 1,2-dichloroethane (30 ml) containing N,Ndiisopropylethylamine (0.6 ml , 3.42 mmol) and the solution (under argon) was cooled in an ice bath. 2-Cyanoethoxy-N,N-diisopropylamino-chlorophosphine (0.4 ml , 1.71 mmol) was added drop wise with stirring during approx. 1 min. The mixture was kept 10 min at 0°C and was then stirred for 1 h at room temperature. TLC in triethylamine/ CH 2 Cl 2 showed a complete reaction with a product spot of Rf. 0.55. Dichloromethane (50 ml) was added and the solution was washed as described above in the standard work-up. The product was purified by column chromatography on silica gel using CH 2 Cl 2 / n-hexane (5:2) containing 2% triethylamine as eluant 
